http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110215512-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76860418b52f9c22202206cbdf960a27 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-1468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8abccf12b377b4eaa8ea41fc9ec913dd |
| publicationDate | 2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110215512-A |
| titleOfInvention | Application of the Chimaerin- α 1 as the signaling molecule for inhibiting headstroke nerve cell functional rehabilitation |
| abstract | The invention belongs to biomedical engineering technology fields, and in particular to application of the Chimaerin- α 1 as the signaling molecule for inhibiting headstroke nerve cell functional rehabilitation.Present invention finds Chimaerin- α 1 in mouse, the expression of the Huanshui River river monkey and human ischemic stroke week area's cortex increases, and it was found that Chimaerin- α 1 inhibits cerebral cortex primary neuron Axonal sprouting and the dendron growth of in vitro culture, limit cerebral cortex apoplexy week area nerve cell Synaptic junction and cynapse, dendritic spines quantity, the expression of Chimaerin- α 1 can hinder headstroke neurological functional recovery, and the expression of Chimaerin- α 1 is blocked, it can promote headstroke neurological functional recovery, therefore, Chimaerin- α 1 can be applied to the medicament research and development of headstroke neurological functional recovery, the research and development of headstroke neurological functional recovery detection kit, 1 retarding agent of Chimaerin- α can be used for treating headstroke, as controlling Treat the effective component of the drug of headstroke. |
| priorityDate | 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.